InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+47.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Hutson Nancy J, Director. Officer active across 5 companies, notably Biocryst Pharmaceuticals INC. Cumulatively, 18 filings have been recorded. Breakdown: 6 buys · 1 sell. Total volume traded: €157k. History available since 28 May 2021. The latest transaction was disclosed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Hutson Nancy J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
12,500 shares0Common StockSEC:0001171843-25-003914:0
7,000 shares@ US$7.5418.2% of flowCommon StockSEC:0001127602-24-029494:0
6,820 shares0Common StockSEC:0001127602-24-018720:0
5,000 shares@ US$6.3810.6% of flowCommon StockSEC:0001127602-24-016190:0
Canonical exit: 18 Aug 2024 (T+90)
10,000 shares@ US$0.865.1% of flowCommon StockSEC:0001209191-23-052027:0
Canonical exit: 1 Jan 2024 (T+90)
16,745 shares0Common StockSEC:0001127602-23-018775:0
3,750 sharesCommon StockSEC:0001169245-23-000027:0
30,000 shares@ US$1.3323.8% of flowCommon StockSEC:0001209191-22-058025:0
Canonical exit: 15 Feb 2023 (T+90)
12,866 shares0Common StockSEC:0001127602-22-017163:0
3,000 shares@ US$3.086.5% of flowCommon StockSEC:0001169245-22-000067:0
Canonical exit: 16 Nov 2021 (T+90)
24,860 shares@ US$2.2686.0% of flowCommon StockSEC:0001169245-21-000106:0
25,000 shares@ US$2.0041.2% of flowCommon StockSEC:0001209191-21-062427:0
30,000 shares@ US$2.9142.1% of flowCommon StockSEC:0001127602-21-027342:0
3,000 shares@ US$3.0814.0% of flowCommon StockSEC:0001169245-21-000083:0
Canonical exit: 16 Nov 2021 (T+90)
3,000 shares@ US$5.6813.9% of flowCommon StockSEC:0001209191-21-051883:0
Canonical exit: 14 Nov 2021 (T+90)
47,924 shares0Ordinary SharesSEC:0001593034-21-000079:0
8,333 shares@ US$2.8510.9% of flowCommon StockSEC:0001127602-21-019792:0
317 shares@ US$15.772.3% of flowCommon StockSEC:0001127602-21-018492:0
18 of 18 declarations
About Hutson Nancy J
Administrateur, Nancy J Hutson has 18 filings in total. Across the sampled recent filings from 2021-06-01 to 2025-06-16, the reported amounts are EUR 106223 of buys and EUR 50391 of sells, with Attribution as the modal transaction nature. She is associated with Biocryst Pharmaceuticals INC, Clearside Biomedical, Inc., PhaseBio Pharmaceuticals Inc and Endo International plc.
